Amoxicillin Dosage for Community-Acquired Pneumonia
For adults without comorbidities, use amoxicillin 1 gram every 8 hours; for children, use 90 mg/kg/day divided into 2 doses (maximum 4 g/day). These high-dose regimens provide optimal coverage against Streptococcus pneumoniae, including strains with reduced penicillin susceptibility.
Adults
Outpatient Treatment
For previously healthy adults without comorbidities, amoxicillin 1 gram every 8 hours is the preferred first-line therapy 1. This recommendation is based on studies demonstrating efficacy of high-dose oral amoxicillin for inpatient CAP, which reasonably extends to outpatients since they are generally lower risk. The high dose overcomes potential resistance issues with pneumococcus while maintaining an excellent safety profile 1.
For adults with comorbidities (chronic heart, lung, liver, or renal disease; diabetes; alcoholism; malignancies; asplenia), combination therapy is preferred:
- Amoxicillin 1 gram every 8 hours PLUS a macrolide (azithromycin or clarithromycin), OR
- Respiratory fluoroquinolone monotherapy (levofloxacin 750 mg daily, moxifloxacin 400 mg daily) 1
FDA-Approved Dosing
The FDA label confirms dosing for lower respiratory tract infections 2:
- Adults and children >40 kg: 875 mg every 12 hours OR 500 mg every 8 hours for mild/moderate to severe infections
- Children <40 kg: 45 mg/kg/day divided every 12 hours OR 40 mg/kg/day divided every 8 hours
Children
Outpatient Treatment (Age ≥3 months)
The preferred dose is amoxicillin 90 mg/kg/day divided into 2 doses 3. This high-dose regimen is critical for:
- Children <5 years with presumed bacterial pneumonia 3
- Children ≥5 years with bacterial CAP (maximum 4 g/day) 3
The 90 mg/kg/day dosing (versus the older 45 mg/kg/day) provides adequate coverage against pneumococcal strains with intermediate penicillin resistance, which is increasingly common 3.
Inpatient Treatment
For hospitalized children who are fully immunized and in areas with minimal penicillin resistance:
For children not fully immunized or in areas with significant penicillin resistance:
- Ceftriaxone (50-100 mg/kg/day every 12-24 hours) or cefotaxime (150 mg/kg/day every 8 hours) 3
Infants <3 months
Maximum dose is 30 mg/kg/day divided every 12 hours due to immature renal function 2. This is a critical safety consideration that prevents drug accumulation.
Duration of Therapy
Recent evidence supports shorter treatment courses when patients achieve clinical stability:
- 3 days for non-severe CAP with clinical stability at day 3 4, 5
- 5 days when stability achieved by day 5 4
- 7 days for other uncomplicated CAP 1, 4
A high-quality pediatric trial demonstrated that 3-day amoxicillin treatment was non-inferior to 7-day treatment for clinical cure, with faster resolution of cough in the 7-day arm (10 vs 12 days) but similar rates of antibiotic retreatment (12.5% in both groups) 6. Multiple meta-analyses confirm that 5-day courses are as effective as 10-day courses for uncomplicated pediatric CAP 7.
Special Populations
Renal Impairment
- GFR 10-30 mL/min: 500 mg or 250 mg every 12 hours 2
- GFR <10 mL/min: 500 mg or 250 mg every 24 hours 2
- Hemodialysis: Additional dose during and after dialysis 2
- Do NOT use 875 mg dose if GFR <30 mL/min 2
Key Considerations
Common pitfalls to avoid:
- Using standard doses (45 mg/kg/day in children, 500 mg TID in adults) instead of high doses—this risks treatment failure with resistant pneumococcus
- Continuing antibiotics beyond clinical stability—this increases resistance without improving outcomes
- Using amoxicillin-clavulanate as first-line when plain amoxicillin suffices—the clavulanate adds cost and GI side effects without benefit for typical CAP pathogens
When to add macrolide coverage:
- Children ≥5 years where atypical pathogens (Mycoplasma, Chlamydophila) cannot be distinguished clinically 3
- Adults with comorbidities 1
- Suspected Legionella (though rare in outpatients) 1
Administration: Take at the start of meals to minimize GI intolerance 2.